{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:32:37Z","timestamp":1793824357881,"version":"4.6.1"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7252270"],"award-info":[{"award-number":["7252270"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L248089"],"award-info":[{"award-number":["L248089"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763729"],"award-info":[{"award-number":["2024M763729"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374224"],"award-info":[{"award-number":["82374224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474324"],"award-info":[{"award-number":["82474324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405182"],"award-info":[{"award-number":["82405182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119011","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:54:31Z","timestamp":1768485271000},"page":"119011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pathogenesis, animal models and pharmacological treatments of hyperuricemia: A systematic review"],"prefix":"10.1016","volume":"195","author":[{"given":"Wenhao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheuma"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1166\/jbn.2019.2752","article-title":"Uricase and Horseradish Peroxidase Hybrid CaHPO\u2084 Nanoflower Integrated with Transcutaneous Patches for Treatment of Hyperuricemia","volume":"15","author":"Hao","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2026.119011_bib3","doi-asserted-by":"crossref","first-page":"j2376","DOI":"10.1136\/bmj.j2376","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","volume":"357","author":"Li","year":"2017","journal-title":"Bmj"},{"issue":"8","key":"10.1016\/j.biopha.2026.119011_bib4","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"6","year":"2024","journal-title":"Lancet Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: a silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.mayocp.2023.01.004","article-title":"Serum Urate and Risk of Chronic Kidney Disease: A Mendelian Randomization Study Using Taiwan Biobank","volume":"98","author":"Tsao","year":"2023","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2026.119011_bib7","article-title":"The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12035-014-9075-0","article-title":"Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis","volume":"53","author":"Yu","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-002203","article-title":"Robust positive association between serum urate and the risk of chronic obstructive pulmonary disease: hospital-based cohort and Mendelian randomisation study","volume":"11","author":"Rao","year":"2024","journal-title":"BMJ Open Respir. Res"},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ana.24281","article-title":"Mendelian randomization of serum urate and parkinson disease progression","volume":"76","author":"Simon","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2026.119011_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211016661","article-title":"Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis","volume":"13","author":"Sharma","year":"2021","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.biopha.2026.119011_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114525","article-title":"Assessing the health risk of hyperuricemia in participants with persistent organic pollutants exposure - a systematic review and meta-analysis","volume":"251","author":"Yu","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"12","key":"10.1016\/j.biopha.2026.119011_bib13","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1007\/s10067-022-06362-1","article-title":"A systematic review and meta-analysis of the hyperuricemia risk from certain metals","volume":"41","author":"Gu","year":"2022","journal-title":"Clin. Rheuma"},{"issue":"8","key":"10.1016\/j.biopha.2026.119011_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41584-024-01137-1","article-title":"The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies","volume":"20","author":"Leask","year":"2024","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.biopha.2026.119011_bib15","article-title":"The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.apsb.2019.10.007","article-title":"Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia","volume":"10","author":"Pan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119011_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118998","article-title":"Creation of an adequate animal model of hyperuricemia (acute and chronic hyperuricemia); study of its reversibility and its maintenance","volume":"268","author":"Dhouibi","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062147","article-title":"High-Protein Diet Induces Hyperuricemia in a New Animal Model for Studying Human Gout","volume":"21","author":"Hong","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119011_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-019-0222-x","article-title":"Mouse models for human hyperuricaemia: a critical review","volume":"15","author":"Lu","year":"2019","journal-title":"Nat. Rev. Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/14656566.2023.2197591","article-title":"Advances in pharmacotherapies for hyperuricemia","volume":"24","author":"Piani","year":"2023","journal-title":"Expert Opin. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib21","doi-asserted-by":"crossref","first-page":"2399213","DOI":"10.1080\/19490976.2024.2399213","article-title":"Empowering probiotics with high xanthine transport for effective hyperuricemia management","volume":"16","author":"Zou","year":"2024","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s11426-020-9923-9","article-title":"Bio-inspired nanoenzyme for metabolic reprogramming and anti-inflammatory treatment of hyperuricemia and gout","volume":"64","author":"Zhang","year":"2021","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.biopha.2026.119011_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108615","article-title":"Uric acid in health and disease: From physiological functions to pathogenic mechanisms","volume":"256","author":"Wen","year":"2024","journal-title":"Pharm. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1248\/bpb.b13-00967","article-title":"Total purine and purine base content of common foodstuffs for facilitating nutritional therapy for gout and hyperuricemia","volume":"37","author":"Kaneko","year":"2014","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10409238.2020.1832438","article-title":"Human de novo purine biosynthesis","volume":"56","author":"Pareek","year":"2021","journal-title":"Crit. Rev. Biochem Mol. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: A review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J. Adv. Res"},{"issue":"7","key":"10.1016\/j.biopha.2026.119011_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads5405","article-title":"Structures and membrane interactions of human OAT1 in complex with clinical used drugs","volume":"11","author":"Wu","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib28","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1038\/s41467-024-49420-9","article-title":"Structural basis for urate recognition and apigenin inhibition of human GLUT9","volume":"15","author":"Shen","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.38884","article-title":"NPT1\/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout","volume":"67","author":"Chiba","year":"2015","journal-title":"Arthritis Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41598-022-26519-x","article-title":"Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients","volume":"13","author":"Ohashi","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119011_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2418282122","article-title":"Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter","volume":"122","author":"Khandelwal","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.dmpk.2020.06.006","article-title":"Mathematical modeling analysis of hepatic uric acid disposition using human sandwich-cultured hepatocytes","volume":"35","author":"Wada","year":"2020","journal-title":"Drug Metab. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2026.119011_bib33","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1681\/ASN.2020040523","article-title":"Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease","volume":"31","author":"Sellmayr","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10287","key":"10.1016\/j.biopha.2026.119011_bib34","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Gout. Lancet"},{"issue":"23","key":"10.1016\/j.biopha.2026.119011_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202308749","article-title":"Monosodium Urate Crystal-Induced Pyroptotic Cell Death in Neutrophil and Macrophage Facilitates the Pathological Progress of Gout","volume":"20","author":"Chen","year":"2024","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib36","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI94584","article-title":"Blocking fatty acid-fueled mROS production within macrophages alleviates acute gouty inflammation","volume":"128","author":"Hall","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib37","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/annrheumdis-2020-217342","article-title":"Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1\u03b2 activation on macrophages","volume":"79","author":"Renaudin","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib38","doi-asserted-by":"crossref","first-page":"688","DOI":"10.17305\/bb.2023.9838","article-title":"Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy","volume":"24","author":"Zhang","year":"2023","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.biopha.2026.119011_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156440","article-title":"Linarin attenuates hyperuricemic nephropathy by modulating Nrf2\/Keap1 and TLR4\/NF-\u03baB signaling pathways: Linarin attenuates hyperuricemic nephropathy","volume":"139","author":"Qian","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119011_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638676","article-title":"Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation via Reduction of Reactive Oxygen Species Production and Lysosomal Rupture","volume":"12","author":"Pan","year":"2021","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib41","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ndt\/gfv024","article-title":"Hyperuricemia-induced inflammasome and kidney diseases","volume":"31","author":"Isaka","year":"2016","journal-title":"Nephrol. Dial. Transpl."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119011_bib43","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1111\/jcmm.15523","article-title":"Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-022-01355-3","article-title":"Distinct changes in endosomal composition promote NLRP3 inflammasome activation","volume":"24","author":"Zhang","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib45","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41467-024-44990-0","article-title":"Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1\u03b2 production","volume":"15","author":"Molina-L\u00f3pez","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41577-022-00787-0","article-title":"Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases","volume":"23","author":"Wigerblad","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119011_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100100","article-title":"A brief review on in vivo models for Gouty Arthritis","volume":"11","author":"Patil","year":"2021","journal-title":"Metab. Open"},{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheuma"},{"issue":"8","key":"10.1016\/j.biopha.2026.119011_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","article-title":"The role of neutrophil extracellular traps in rheumatic diseases","volume":"14","author":"Apel","year":"2018","journal-title":"Nat. Rev. Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004651","article-title":"Neutrophils: Between host defence, immune modulation, and tissue injury","volume":"11","author":"Kruger","year":"2015","journal-title":"PLoS Pathog."},{"issue":"673","key":"10.1016\/j.biopha.2026.119011_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax7942","article-title":"The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps","volume":"14","author":"Apel","year":"2021","journal-title":"Sci. Signal"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib52","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s10753-022-01676-3","article-title":"Anti-inflammatory and Antioxidant Effect of Poly-gallic Acid (PGAL) in an In Vitro Model of Synovitis Induced by Monosodium Urate Crystals","volume":"45","author":"Zamudio-Cuevas","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2026.119011_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.sbi.2019.03.001","article-title":"Structure and mechanisms of ROS generation by NADPH oxidases","volume":"59","author":"Magnani","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119011_bib55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.chemosphere.2017.06.006","article-title":"A ROS-mediated mitochondrial pathway and Nrf2 pathway activation are involved in BDE-47 induced apoptosis in Neuro-2a cells","volume":"184","author":"Chen","year":"2017","journal-title":"Chemosphere"},{"key":"10.1016\/j.biopha.2026.119011_bib56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-arplant-050312-120132","article-title":"ROS-mediated lipid peroxidation and RES-activated signaling","volume":"64","author":"Farmer","year":"2013","journal-title":"Annu Rev. Plant Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib57","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/thno.50905","article-title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.biopha.2026.119011_bib58","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/jcp.31038","article-title":"Hyperuricemia promotes the progression of atherosclerosis by activating endothelial cell pyroptosis via the ROS\/NLRP3 pathway","volume":"238","author":"He","year":"2023","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2026.119011_bib59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13980","article-title":"Uric acid transport, transporters, and their pharmacological targeting","volume":"238","author":"Adomako","year":"2023","journal-title":"Acta Physiol. (Oxf. )"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib61","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.00009.2021","article-title":"Regulation of solute carriers oct2 and OAT1\/3 in the kidney: a phylogenetic, ontogenetic, and cell dynamic perspective","volume":"102","author":"Pou Casellas","year":"2022","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib62","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J. Clin. Invest"},{"issue":"9","key":"10.1016\/j.biopha.2026.119011_bib63","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"issue":"8","key":"10.1016\/j.biopha.2026.119011_bib64","article-title":"The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy","volume":"5","author":"Hu","year":"2024","journal-title":"Cell Rep. Med"},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib65","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s12265-024-10526-6","article-title":"CRISPR\/Cas9 Mediated Deletion of the Uox Gene Generates a Mouse Model of Hyperuricemia with Multiple Complications","volume":"17","author":"Zeng","year":"2024","journal-title":"J. Cardiovasc Transl. Res"},{"issue":"ement_1","key":"10.1016\/j.biopha.2026.119011_bib66","article-title":"Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study","volume":"42","author":"Kiddle","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/med.21742","article-title":"Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence","volume":"41","author":"Jayachandran","year":"2021","journal-title":"Med Res Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.026","article-title":"Hyperuricemia induces hypertension through activation of renal epithelial sodium channel (ENaC)","volume":"65","author":"Xu","year":"2016","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib69","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","article-title":"Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study","volume":"69","author":"Kuwabara","year":"2017","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.biopha.2026.119011_bib70","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1055\/a-2299-2914","article-title":"Association Between Remnant Cholesterol and Risk of Hyperuricemia: A Cross-Sectional Study","volume":"56","author":"Wang","year":"2024","journal-title":"Horm. Metab. Res"},{"key":"10.1016\/j.biopha.2026.119011_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1286206","article-title":"Interaction between anemia and hyperuricemia in the risk of all-cause mortality in patients with chronic kidney disease","volume":"15","author":"Lu","year":"2024","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147737","article-title":"High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo","volume":"11","author":"Zhi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119011_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/art.43118","article-title":"The Gut Microbiome in Hyperuricemia and Gout","author":"Terkeltaub","year":"2025","journal-title":"Arthritis Rheuma"},{"issue":"9","key":"10.1016\/j.biopha.2026.119011_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.255","article-title":"Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-\u03baB signaling in macrophages and protecting endothelial cells","volume":"7","author":"Han","year":"2016","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00011-016-1008-0","article-title":"Macrophage-derived IL-1\u03b2 enhances monosodium urate crystal-triggered NET formation","volume":"66","author":"Sil","year":"2017","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.biopha.2026.119011_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110466","article-title":"Immune and inflammatory mechanisms and therapeutic targets of gout: An update","volume":"121","author":"Liu","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib78","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/art.41779","article-title":"Assessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization","volume":"73","author":"McCormick","year":"2021","journal-title":"Arthritis Rheuma"},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib79","doi-asserted-by":"crossref","DOI":"10.1097\/IMNA-D-23-00008","article-title":"Hyperuricemia-Induced Acute Kidney Injury in the Context of Chronic Kidney Disease: A Case Report","volume":"10","author":"Du","year":"2023","journal-title":"Integr. Med. Nephrol. Androl."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/rheumatology\/kez384","article-title":"Monosodium urate crystal interleukin-1\u03b2 release is dependent on Toll-like receptor 4 and transient receptor potential V1 activation","volume":"59","author":"Rossato","year":"2020","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2026.119011_bib81","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2017.00010","article-title":"C5a Regulates IL-1\u03b2 Production and Leukocyte Recruitment in a Murine Model of Monosodium Urate Crystal-Induced Peritonitis","volume":"8","author":"Khameneh","year":"2017","journal-title":"Front Pharm."},{"issue":"7734","key":"10.1016\/j.biopha.2026.119011_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","article-title":"PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation","volume":"564","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.287","article-title":"Impaired Na(+)-K(+)-ATPase signaling in renal proximal tubule contributes to hyperuricemia-induced renal tubular injury","volume":"50","author":"Xiao","year":"2018","journal-title":"Exp. Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib84","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12882-019-1506-8","article-title":"Uric acid regulates NLRP3\/IL-1\u03b2 signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K(+) efflux","volume":"20","author":"Yin","year":"2019","journal-title":"BMC Nephrol."},{"issue":"16","key":"10.1016\/j.biopha.2026.119011_bib85","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib86","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12020-012-9629-8","article-title":"Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome","volume":"41","author":"Gon\u00e7alves","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.biopha.2026.119011_bib87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.archger.2016.01.005","article-title":"Serum uric acid concentration and metabolic syndrome among elderly Koreans: The Korean Urban Rural Elderly (KURE) study","volume":"64","author":"Choi","year":"2016","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.biopha.2026.119011_bib88","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cca.2015.04.019","article-title":"Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome: Results from Fangchenggang Area Male Health and Examination Survey in China","volume":"446","author":"Chen","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2026.119011_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102271","article-title":"U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia","volume":"51","author":"Crawley","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12872-016-0379-z","article-title":"Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies","volume":"16","author":"Zuo","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"issue":"9129","key":"10.1016\/j.biopha.2026.119011_bib91","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0140-6736(05)60816-1","article-title":"Uric acid as an independent risk factor in the treatment of hypertension","volume":"352","author":"Ward","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11926-023-01100-1","article-title":"Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout","volume":"25","author":"Leung","year":"2023","journal-title":"Curr. Rheuma Rep."},{"key":"10.1016\/j.biopha.2026.119011_bib93","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12891-015-0762-4","article-title":"Factors influencing the crystallization of monosodium urate: a systematic literature review","volume":"16","author":"Chhana","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib94","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","article-title":"Loss of urate oxidase activity in hominoids and its evolutionary implications","volume":"19","author":"Oda","year":"2002","journal-title":"Mol. Biol. Evol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib95","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1073\/pnas.91.2.742","article-title":"Hyperuricemia and urate nephropathy in urate oxidase-deficient mice","volume":"91","author":"Wu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119011_bib96","first-page":"129","article-title":"ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches","volume":"10","author":"Cleophas","year":"2017","journal-title":"Pharmgenomics Pers. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.kint.2017.04.031","article-title":"Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders","volume":"93","author":"Lu","year":"2018","journal-title":"Kidney Int"},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119011_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000056953","article-title":"Mouse paracentric inversion In(3)55Rk mutates the urate oxidase gene","volume":"93","author":"Cook","year":"2001","journal-title":"Cytogenet Cell Genet"},{"issue":"36","key":"10.1016\/j.biopha.2026.119011_bib99","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1073\/pnas.0904411106","article-title":"Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy","volume":"106","author":"Preitner","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119011_bib100","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1038\/ncomms5642","article-title":"Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9","volume":"5","author":"DeBosch","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2026.119011_bib101","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00424-018-2190-4","article-title":"SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney","volume":"470","author":"Auberson","year":"2018","journal-title":"Pflug. Arch."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib102","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1681\/ASN.2009040406","article-title":"Homozygous SLC2A9 mutations cause severe renal hypouricemia","volume":"21","author":"Dinour","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"25","key":"10.1016\/j.biopha.2026.119011_bib103","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000237","article-title":"Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population","volume":"1","author":"Matsuo","year":"2009","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2026.119011_bib105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119011_bib106","article-title":"New mouse model of gout risk variant, ABCG2 Q141K, reveals unexpectedly severe molecular and functional defect in ABCG2 mediated intestinal uric acid secretion","author":"Hoque","year":"2017","journal-title":"WILEY 111 RIVER ST HOBOKEN 070305774 NJ USA"},{"key":"10.1016\/j.biopha.2026.119011_bib107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jare.2022.11.003","article-title":"Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia","volume":"52","author":"Wang","year":"2023","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.biopha.2026.119011_bib108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jchromb.2017.06.037","article-title":"Lipidomics to investigate the pharmacologic mechanisms of ginkgo folium in the hyperuricemic rat model","volume":"1060","author":"Zhang","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.biopha.2026.119011_bib109","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5007488","article-title":"Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury","volume":"2023","author":"Sui","year":"2023","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib110","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1038\/s41598-021-88872-7","article-title":"Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway","volume":"11","author":"Cho","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119011_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154868","article-title":"Amelioration effects of \u03b1-viniferin on hyperuricemia and hyperuricemia-induced kidney injury in mice","volume":"116","author":"Guo","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1897211","article-title":"Limosilactobacillus fermentum JL-3 isolated from \"Jiangshui\" ameliorates hyperuricemia by degrading uric acid","volume":"13","author":"Wu","year":"2021","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib113","doi-asserted-by":"crossref","first-page":"2070391","DOI":"10.1080\/19490976.2022.2070391","article-title":"Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment","volume":"14","author":"Zhao","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2026.119011_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109195","article-title":"Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice","volume":"118","author":"Chen","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jphs.2017.11.011","article-title":"The uricosuric effects of dihydropyridine calcium channel blockers in vivo using urate under-excretion animal models","volume":"136","author":"Hori","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib116","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7150\/ijbs.33007","article-title":"Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK\/AKT\/CREB Signaling Pathway in Type 2 Diabetic Mice","volume":"16","author":"Lu","year":"2020","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2026.119011_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153552","article-title":"Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6\/JAK2\/STAT3 and TGF-\u03b2\/SMAD3 signaling","volume":"87","author":"Ren","year":"2021","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib118","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds","volume":"62","author":"Xu","year":"2015","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119011_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/foods13091371","article-title":"Lacticaseibacillus paracasei JS-3 Isolated from \"Jiangshui\" Ameliorates Hyperuricemia by Regulating Gut Microbiota and iTS Metabolism","volume":"13","author":"Wu","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.biopha.2026.119011_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110719","article-title":"Chicory ameliorates hyperuricemia via modulating gut microbiota and alleviating LPS\/TLR4 axis in quail","volume":"131","author":"Bian","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119011_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1074867","article-title":"Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119011_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1300131","article-title":"Ameliorative action of \"daitongxiao\" against hyperuricemia includes the \"uric acid transporter group\"","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib123","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1081\/DCT-52559","article-title":"Gout induced by intoxication of sodium bicarbonate in Korean native broilers","volume":"28","author":"Ejaz","year":"2005","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.biopha.2026.119011_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1173856","article-title":"Bacteroides xylanisolvens possesses a potent anti-hyperuricemia effect in goslings fed on a high-protein diet","volume":"14","author":"Song","year":"2023","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib125","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15160","article-title":"Zebrafish model of hyperuricemia","volume":"27","author":"Deng","year":"2024","journal-title":"Int J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2018.11.050","article-title":"A zebrafish (Danio rerio) model for high-throughput screening food and drugs with uric acid-lowering activity","volume":"508","author":"Zhang","year":"2019","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2026.119011_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106681","article-title":"A natural complex product Yaocha reduces uric acid level in a live zebrafish model","volume":"102","author":"Xiong","year":"2020","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"12","key":"10.1016\/j.biopha.2026.119011_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/genes13122179","article-title":"Uricase-Deficient Larval Zebrafish with Elevated Urate Levels Demonstrate Suppressed Acute Inflammatory Response to Monosodium Urate Crystals and Prolonged Crystal Persistence","volume":"13","author":"Linnerz","year":"2022","journal-title":"Genes (Basel)"},{"issue":"9","key":"10.1016\/j.biopha.2026.119011_bib129","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/molbev\/msw116","article-title":"Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout","volume":"33","author":"Tan","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.biopha.2026.119011_bib130","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8971","article-title":"Uricase-deficient rat is generated with CRISPR\/Cas9 technique","volume":"8","author":"Yu","year":"2020","journal-title":"PeerJ"},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib131","doi-asserted-by":"crossref","first-page":"F786","DOI":"10.1152\/ajprenal.00083.2013","article-title":"Urate-induced acute renal failure and chronic inflammation in liver-specific Glut9 knockout mice","volume":"305","author":"Preitner","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4-6","key":"10.1016\/j.biopha.2026.119011_bib132","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/15257771003738634","article-title":"Establishment and analysis of SLC22A12 (URAT1) knockout mouse","volume":"29","author":"Hosoyamada","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"10-12","key":"10.1016\/j.biopha.2026.119011_bib133","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/15257770.2016.1143559","article-title":"Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury","volume":"35","author":"Hosoyamada","year":"2016","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"31","key":"10.1016\/j.biopha.2026.119011_bib134","doi-asserted-by":"crossref","first-page":"18175","DOI":"10.1073\/pnas.2006958117","article-title":"Identification of GLUT12\/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice","volume":"117","author":"Toyoda","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4-6","key":"10.1016\/j.biopha.2026.119011_bib135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/15257770.2013.854902","article-title":"ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion","volume":"33","author":"Takada","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib136","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00424-007-0239-x","article-title":"Down regulation of small intestinal ion transport in PDZK1- (CAP70\/NHERF3) deficient mice","volume":"454","author":"Hillesheim","year":"2007","journal-title":"Pflug. Arch."},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173512","article-title":"The renal phenotype of allopurinol-treated HPRT-deficient mouse","volume":"12","author":"Zennaro","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib138","doi-asserted-by":"crossref","first-page":"F1062","DOI":"10.1152\/ajprenal.00233.2017","article-title":"Tamm-Horsfall protein\/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia","volume":"314","author":"Liu","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib139","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1039\/C8FO01480A","article-title":"Anti-hyperuricemic and nephroprotective effects of extracts from Chaenomeles sinensis (Thouin) Koehne in hyperuricemic mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Food Funct."},{"issue":"12","key":"10.1016\/j.biopha.2026.119011_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/md16120472","article-title":"Production Inhibition and Excretion Promotion of Urate by Fucoidan from Laminaria japonica in Adenine-Induced Hyperuricemic Mice","volume":"16","author":"Zhang","year":"2018","journal-title":"Mar. Drugs"},{"issue":"10","key":"10.1016\/j.biopha.2026.119011_bib141","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.phymed.2014.03.009","article-title":"Riparoside B and timosaponin J, two steroidal glycosides from Smilax riparia, resist to hyperuricemia based on URAT1 in hyperuricemic mice","volume":"21","author":"Wu","year":"2014","journal-title":"Phytomedicine"},{"issue":"1-3","key":"10.1016\/j.biopha.2026.119011_bib142","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejphar.2011.05.021","article-title":"Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice","volume":"666","author":"Li","year":"2011","journal-title":"Eur. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib143","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.kint.2020.05.056","article-title":"Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease","volume":"98","author":"Ponticelli","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib144","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41467-025-56843-5","article-title":"Mechanisms of urate transport and uricosuric drugs inhibition in human URAT1","volume":"16","author":"Guo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119011_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106298","article-title":"Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia","volume":"89","author":"Martens","year":"2020","journal-title":"Leuk. Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib146","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2017.20189","article-title":"Lesinurad\/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia","volume":"319","year":"2018","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib147","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib148","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/07853890.2016.1243803","article-title":"Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis","volume":"49","author":"Qu","year":"2017","journal-title":"Ann. Med. Mar."},{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib149","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"22","key":"10.1016\/j.biopha.2026.119011_bib150","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/eurheartj\/ehz119","article-title":"Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy","volume":"40","author":"Kojima","year":"2019","journal-title":"Eur. Heart J. Jun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib151","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10067-016-3474-8","article-title":"Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study","volume":"36","author":"Hosoya","year":"2017","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.biopha.2026.119011_bib152","first-page":"145","article-title":"New and improved strategies for the treatment of gout","volume":"3","author":"Dubchak","year":"2010","journal-title":"Int J. Nephrol. Renov. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib153","article-title":"Uricosuric medications for chronic gout","volume":"2014","author":"Kydd","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2026.119011_bib154","article-title":"Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia","volume":"12","author":"Sun","year":"2021","journal-title":"Front Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2026.119011_bib155","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/14656566.2021.1918102","article-title":"Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout","volume":"22","author":"Ishikawa","year":"2021","journal-title":"Expert Opin. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib156","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10157-020-01849-0","article-title":"Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study","volume":"24","author":"Hosoya","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib157","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/BOR.0000000000000146","article-title":"New medications in development for the treatment of hyperuricemia of gout","volume":"27","author":"Diaz-Torn\u00e9","year":"2015","journal-title":"Curr. Opin. Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib158","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40264-014-0255-7","article-title":"Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) project","volume":"38","author":"Allen","year":"2015","journal-title":"Drug Saf."},{"issue":"9","key":"10.1016\/j.biopha.2026.119011_bib159","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3899\/jrheum.110092","article-title":"Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions","volume":"38","author":"Chohan","year":"2011","journal-title":"J. Rheuma"},{"key":"10.1016\/j.biopha.2026.119011_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152279","article-title":"Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies","volume":"63","author":"Qu","year":"2023","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.biopha.2026.119011_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.947959","article-title":"Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials","volume":"9","author":"Ma","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib162","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cpt.1377","article-title":"Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis","volume":"106","author":"Chen","year":"2019","journal-title":"Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib163","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/acr.22409","article-title":"Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea","volume":"67","author":"Park","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089967","article-title":"The curious case of benzbromarone: insight into super-inhibition of cytochrome P450","volume":"9","author":"Parashar","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000861","article-title":"Update on gout management: what is old and what is new","volume":"34","author":"Afinogenova","year":"2022","journal-title":"Curr. Opin. Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2026.119011_bib166","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ki.2013.276","article-title":"Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases","volume":"84","author":"Zhong","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2026.119011_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1128699","article-title":"Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid","volume":"14","author":"An","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119011_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114379","article-title":"Synthesis and biological evaluation of geniposide derivatives as inhibitors of hyperuricemia, inflammatory and fibrosis","volume":"237","author":"Chen","year":"2022","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2026.119011_bib169","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.phymed.2018.02.002","article-title":"Luteolin-4\u2032-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models","volume":"1","author":"Lin","year":"2018","journal-title":"Phytomedicine. Mar."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2026.119011_bib170","article-title":"Hesperetin acts as a potent xanthine oxidase inhibitor: New evidence from its reactive oxygen suppression and enzyme binding","volume":"306","author":"Liu","year":"2025","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2026.119011_bib171","article-title":"Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase","volume":"80","author":"Chen","year":"2021","journal-title":"Phytomedicine. Jan."},{"key":"10.1016\/j.biopha.2026.119011_bib172","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.biopha.2018.11.022","article-title":"Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy","volume":"109","author":"Pan","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib173","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.foodchem.2012.04.026","article-title":"Protection of curcumin against fructose-induced hyperuricaemia and renal endothelial dysfunction involves NO-mediated JAK-STAT signalling in rats","volume":"134","author":"Zhang","year":"2012","journal-title":"Food Chem."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2026.119011_bib174","article-title":"Integrating metabolomics with network pharmacology to reveal the mechanism of Poria cocos in hyperuricemia treatment","volume":"337","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110449","article-title":"Kidney tea ameliorates hyperuricemia in mice via altering gut microbiota and restoring metabolic profile","volume":"376","author":"Chen","year":"2023","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2026.119011_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116770","article-title":"The antihyperuricemia activity of Astragali Radix through regulating the expression of uric acid transporters via PI3K\/Akt signalling pathway","volume":"317","author":"Zhang","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib177","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12906-021-03350-x","article-title":"Lipidomics study of the therapeutic mechanism of Plantaginis Semen in potassium oxonate-induced hyperuricemia rat","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Complement Med Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib178","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jep.2011.03.033","article-title":"Anti-hyperuricemic and nephroprotective effects of Smilax china L","volume":"135","author":"Chen","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib179","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1038\/s41598-024-66454-7","article-title":"Anti-hyperuricemia effect of Clerodendranthus spicatus: a molecular biology study combined with metabolomics","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119011_bib180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/DDDT.S398625","article-title":"Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation","volume":"17","author":"Huang","year":"2023","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2026.119011_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114545","article-title":"Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia","volume":"281","author":"Shan","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib182","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jep.2014.12.001","article-title":"Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice","volume":"161","author":"Sun","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib183","article-title":"The Anti-Inflammatory and Uric Acid Lowering Effects of Si-Miao-San on Gout","volume":"12","author":"Cao","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119011_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118492","article-title":"Simiao pills alleviates renal injury associated with hyperuricemia: A multi-omics analysis","volume":"333","author":"Zeng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib185","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2146204","article-title":"Efficacy and Safety of Chinese Medicinal Herbs for the Treatment of Hyperuricemia: A Systematic Review and Meta-Analysis","volume":"2016","author":"Lin","year":"2016","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib186","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/13880209.2021.1885450","article-title":"Hypouricaemic and nephroprotective effects of Poria cocos in hyperuricemic mice by up-regulating ATP-binding cassette super-family G member 2","volume":"59","author":"Liang","year":"2021","journal-title":"Pharm. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib187","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12906-020-03119-8","article-title":"Xanthine oxidase inhibitory activity of a new isocoumarin obtained from Marantodes pumilum var. pumila leaves","volume":"20","author":"Aladdin","year":"2020","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.biopha.2026.119011_bib188","article-title":"Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions","author":"Han","year":"2024","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.biopha.2026.119011_bib189","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/DDDT.S389811","article-title":"A Novel Approach Based on Gut Microbiota Analysis and Network Pharmacology to Explain the Mechanisms of Action of Cichorium intybus L. Formula in the Improvement of Hyperuricemic Nephropathy in Rats","volume":"17","author":"Amatjan","year":"2023","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2026.119011_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114532","article-title":"In vivo anti-hyperuricemia and anti-gouty arthritis effects of the ethanol extract from Amomumvillosum Lour","volume":"161","author":"Dong","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119011_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118254","article-title":"Piper longum L. ameliorates gout through the MAPK\/PI3K-AKT pathway","volume":"330","author":"Wu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118618","article-title":"Ilex cornuta leaves extracts ameliorate hyperuricemia by modulating uric acid transporters","volume":"336","author":"Mao","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153765","article-title":"Antihyperuricemia and antigouty arthritis effects of Persicaria capitata herba in mice","volume":"93","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119011_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.11.032","article-title":"Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice","volume":"59","author":"Liang","year":"2019","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.biopha.2026.119011_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/nu16020184","article-title":"Chinese Sumac (Rhus chinensis Mill.) Fruits Prevent Hyperuricemia and Uric Acid Nephropathy in Mice Fed a High-Purine Yeast Diet","volume":"16","author":"Ma","year":"2024","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.biopha.2026.119011_bib196","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1039\/C9FO00509A","article-title":"Effect of lemon water soluble extract on hyperuricemia in a mouse model","volume":"10","author":"Chen","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2026.119011_bib197","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jep.2017.03.057","article-title":"Effects of Gnaphalium affine D. Don on hyperuricemia and acute gouty arthritis","volume":"203","author":"Zhang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib198","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2147\/DDDT.S407983","article-title":"16S rRNA and Metagenomics Combined with UPLC-Q\/TOF-MS Metabolomics Analysis Reveals the Potential Mechanism of Radix Astragali Against Hyperuricemia in Mice","volume":"17","author":"Deng","year":"2023","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2026.119011_bib199","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jep.2014.11.051","article-title":"Sa\u00fade-Guimar\u00e3es DA. Effects of extracts of leaves from Sparattosperma leucanthum on hyperuricemia and gouty arthritis","volume":"161","author":"Lemos Lima Rde","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118488","article-title":"The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid","volume":"333","author":"Jiao","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"24","key":"10.1016\/j.biopha.2026.119011_bib201","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1039\/D4FO03481C","article-title":"Mulberry (Fructus mori) extract alleviates hyperuricemia by regulating urate transporters and modulating the gut microbiota","volume":"15","author":"Fang","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2026.119011_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112040","article-title":"Sa\u00fade-Guimar\u00e3es DA. Lychnophora pinaster ethanolic extract and its chemical constituents ameliorate hyperuricemia and related inflammation","volume":"242","author":"Martins de S\u00e1 M\u00fcller","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119011_bib203","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1039\/C9FO01821B","article-title":"Identifying mechanisms underlying the amelioration effect of Chrysanthemum morifolium Ramat. 'Boju' extract on hyperuricemia using biochemical characterization and UPLC-ESI-QTOF\/MS-based metabolomics","volume":"10","author":"Peng","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2026.119011_bib204","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biopha.2018.06.163","article-title":"Research on the pharmacodynamics and mechanism of Fraxini Cortex on hyperuricemia based on the regulation of URAT1 and GLUT9","volume":"106","author":"Zhou","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2026.119011_bib205","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14140","article-title":"Effects of black tea and black brick tea with fungal growth on lowering uric acid levels in hyperuricemic mice","volume":"46","author":"Yuan","year":"2022","journal-title":"J. Food Biochem"},{"issue":"7","key":"10.1016\/j.biopha.2026.119011_bib206","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1039\/C9FO02246E","article-title":"Anti-hyperuricemic potential of stevia (Stevia rebaudiana Bertoni) residue extract in hyperuricemic mice","volume":"11","author":"Mehmood","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2026.119011_bib207","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jep.2017.12.004","article-title":"Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia","volume":"214","author":"Zhang","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"17","key":"10.1016\/j.biopha.2026.119011_bib208","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1039\/D4FO02391A","article-title":"A metabolomics perspective reveals the mechanism of the uric acid-lowering effect of Prunus salicina Lindl. cv. \"furong\" polyphenols in hypoxanthine and potassium oxybate-induced hyperuricemic mice","volume":"15","author":"Wu","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2026.119011_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113278","article-title":"Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice","volume":"264","author":"Pan","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119011_bib210","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101381","article-title":"DKB114, A Mixture of Chrysanthemum Indicum Linne Flower and Cinnamomum cassia (L.) J. Presl Bark Extracts, Improves Hyperuricemia through Inhibition of Xanthine Oxidase Activity and Increasing Urine Excretion","volume":"10","author":"Lee","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119011_bib211","article-title":"Analyzing chemical composition of Sargentodoxae caulis water extract and their hypouricemia effect in hyperuricemic mice","volume":"175","author":"Liu","year":"2024","journal-title":"Fitoter. Jun."},{"issue":"4","key":"10.1016\/j.biopha.2026.119011_bib212","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/09168451.2014.890028","article-title":"Administered chrysanthemum flower oil attenuates hyperuricemia: mechanism of action as revealed by DNA microarray analysis","volume":"78","author":"Honda","year":"2014","journal-title":"Biosci. Biotechnol. Biochem"},{"issue":"18","key":"10.1016\/j.biopha.2026.119011_bib213","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183248","article-title":"Constituents and Anti-Hyperuricemia Mechanism of Traditional Chinese Herbal Formulae Erding Granule","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119011_bib214","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biopha.2017.04.031","article-title":"Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats","volume":"91","author":"Huijuan","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119011_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118410","article-title":"Elucidating the substance basis and pharmacological mechanism of Fufang Qiling granules in modulating xanthine oxidase for intervention in hyperuricemia","volume":"333","author":"Ye","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2026.119011_bib216","article-title":"Mechanism of Biqi capsules in the treatment of gout based on network pharmacology and experimental verification","volume":"337","author":"Li","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2026.119011_bib217","article-title":"Fangyukangsuan granules ameliorate hyperuricemia and modulate gut microbiota in rats","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119011_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116736","article-title":"Integrated network pharmacology and gut microbiome analysis to reveal the mechanism of Qu-Zhuo-Tong-Bi decoction against hyperuricemia and gout","volume":"316","author":"Song","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119011_bib219","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23949","article-title":"The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia","volume":"35","author":"Wu","year":"2021","journal-title":"J. Clin. Lab Anal."},{"issue":"30","key":"10.1016\/j.biopha.2026.119011_bib220","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.2174\/0929867326666181211094421","article-title":"Mechanistic Insights of Soluble Uric Acid-related Kidney Disease","volume":"27","author":"Shi","year":"2020","journal-title":"Curr. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib221","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/imr.12833","article-title":"Urate-induced immune programming: Consequences for gouty arthritis and hyperuricemia","volume":"294","author":"Cab\u0103u","year":"2020","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2026.119011_bib222","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","article-title":"Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study","volume":"74","author":"Dalbeth","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib223","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4049\/jimmunol.2000319","article-title":"Soluble Uric Acid Is an Intrinsic Negative Regulator of Monocyte Activation in Monosodium Urate Crystal-Induced Tissue Inflammation","volume":"205","author":"Ma","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119011_bib224","article-title":"Folic acid and zinc improve hyperuricemia by altering the gut microbiota of rats with high-purine diet-induced hyperuricemia","volume":"13","author":"Sun","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biopha.2026.119011_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.crfs.2024.100864","article-title":"Energy insufficiency induced by high purine diet: Catalysts for renal impairment in hyperuricemia nephropathy rat model","volume":"9","author":"Zhao","year":"2024","journal-title":"Curr. Res Food Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119011_bib226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13813455.2019.1610779","article-title":"Natural products for the management of hyperuricaemia and gout: a review","volume":"127","author":"El-Tantawy","year":"2021","journal-title":"Arch. Physiol. Biochem"},{"issue":"3","key":"10.1016\/j.biopha.2026.119011_bib227","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/hr.2016.139","article-title":"Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia","volume":"40","author":"Ohta","year":"2017","journal-title":"Hypertens. Res"},{"key":"10.1016\/j.biopha.2026.119011_bib228","article-title":"Therapeutic potential and pharmacological mechanisms of Traditional Chinese Medicine in gout treatment","author":"Guo","year":"2025","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2026.119011_bib229","article-title":"Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:59:57Z","timestamp":1773979197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":229,"alternative-id":["S0753332226000430"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119011","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis, animal models and pharmacological treatments of hyperuricemia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119011"}}